Management of thrombosis in a neuro-oncology patient

Oncology Nursing Forum

Volumn 34, Issue 4, 2007, Pages 777-781

  Eisenson, Nancy ^a  

^a DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CASE REPORT; ECHOGRAPHY; HUMAN; LEG; MALE; METHODOLOGY; NURSING; ONCOLOGY NURSING; PATIENT EDUCATION; SELF MEDICATION; SUBCUTANEOUS DRUG ADMINISTRATION; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; ASTROCYTOMA; BRAIN NEOPLASMS; ENOXAPARIN; HUMANS; INJECTIONS, SUBCUTANEOUS; LEG; MALE; ONCOLOGIC NURSING; PATIENT EDUCATION AS TOPIC; SELF MEDICATION; VENOUS THROMBOSIS;

EID: 38549117372     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/07.ONF.777-782     Document Type: Article

References (32)

1. Blom, J.W., Doggen, C.J., Osanto, S., & Rosendaal, F.R. (2005). Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA, 293, 715-722.
2. Bristol-Myers Squibb. (2006). Coumadin® prescribing information. Retrieved February 12, 2007, from http://www.bms.com/cgi-bin/anybin.pl?sql= PPI_SEQ=91&key=PPI
3. Buller, H.R., Agnelli, G., Hull, R.D., Hyers, T.M., Prins, M.H., & Raskob, G.E. (2004). Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest, 126(Suppl.), 401S-428S.
4. Cervantes, J., & Rojas, G. (2005). Virchow's legacy: Deep vein thrombosis and pulmonary embolism. World Journal of Surgery, 29(Suppl. 11), S30-S34.
5. Gage, B.F., Fihn, S.D., & White, R.H. (2000). Management and dosing of warfarin therapy. American Journal of Medicine, 109, 481-488.
6. Gerber, D., Grossman, S., & Streiff, M. (2006). Management of venous thromboembolism in patients with primary and metastatic brain tumors. Journal of Clinical Oncology, 24, 1310-1318.
7. Goldhaber, S.Z., Dunn, K., Gerhard-Herman, M., Park, J.K., & Black, P.M. (2002). Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest, 122, 1933-1937.
8. Greenblatt, D.J., & von Moltke, L.L. (2005). Interaction of warfarin with drugs, natural substances, and foods. Journal of Clinical Pharmacology, 45, 127-132.
9. Kane, D., Balint, P.V., Gibney, B., Bresniham, R., & Sturrock, R.D. (2004). Differential diagnosis of calf pain with musculoskeletal ultrasound imaging. Annals of the Rheumatic Diseases, 63, 11-14.
10. Katz, D.S., & Hon, M. (2004). Current DVT imaging. Techniques in Vascular and Interventional Radiology, 7, 55-82.
11. Kleihues, P., Burger, P.C., & Scheithauer, B.W. (1993). The new WHO classification of brain tumours. Brain Pathology, 3, 255-268.
12. Knovich, M., & Lesser, G. (2004). The management of thromboembolic disease in patients with central nervous system malignancies. Current Treatment Options in Oncology, 5, 511-517.
13. Kyrle, P.A., & Eichinger, S. (2005). Deep vein thrombosis. Lancet, 365, 1163-1174.
14. Lee, A.Y., Levine, M.N., Baker, R.I., Bowden, C., Kakkar, A.K., Prins, M., et al. (2003). Low-molecular-weight heparin versus coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. New England Journal of Medicine, 349, 146-153.
15. Lin, J., Wakefield, T., & Henke, P. (2006). Factors associated with venous thromboembolic events in patients with malignancy. Blood Coagulation and Fibrinolysis, 17, 265-270.
16. Line, B.R. (2001). Pathophysiology and diagnosis of deep vein thrombosis. Vascular and Thromboembolic Disease, 31, 90-101.
17. Luyendyk, J., Tilley, R., & Mackman, N. (2006). Genetic susceptibility to thrombosis. Current Atherosclerotic Research, 8, 193-197.
18. Meissner, M.H., & Strandness, D.E., Jr. (2001). The epidemiology and natural history of acute deep vein thrombosis. In P. Gloviczki & J.S.T. Yao (Eds.), Handbook of venous disorders: Guidelines of the American Venous Forum (2nd ed., pp. 36-48). London: Arnold.
19. National Cancer Institute. (2000). National Cancer Institute Brain Tumor Study in adults: Fact sheet. Retrieved February 13, 2007, from http://www.cancer.gov/cancertopics/factsheet/braintumorstudy
20. National Comprehensive Cancer Network. (2006). Clinical practice guidelines in oncology: Venous thromboembolic disease. Retrieved February 15, 2007, from http://www.nccn.org/professionals/physician_gls/PDF/vte.pdf
21. Preumer, J. (2006). Treatment of cancer-associated thrombosis: Distinguishing among antithrombotic agents. Seminars in Oncology, 33(Suppl. 4), 26-39.
22. Qaseem, A., Snow, V., Barry, P., Hornbake, E.R., Rodnick, J.E., Tobolic, T., et al. (2007). Current diagnosis of venous thromboembolism in primary care: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Annals of Family Medicine, 5, 57-62.
23. sanofi-aventis. (2006). Lovenox® prescribing information. Retrieved February 8, 2007, from http://products.sanofi-aventis.us/lovenox/lovenox.html
24. Sanoski, C.A., & Bauman, J.L. (2002). Clinical observations with the amiodarone/warfarin interaction: Dosing relationships with long-term therapy. Chest, 121, 19-23.
25. Schreiber, D.H. (2002). The role of D-dimer in the diagnosis of venous thromboembolism. Laboratory Medicine, 33, 136-144.
26. Sciacca, F.L., Ciusani, E., Silvani, A., Corsini, E., Frigerio, S., Pogliani, S., et al. (2004). Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Clinical Cancer Research, 10, 1312-1317.
27. Snow, V., Qaseem, A., Barry, P., Hornbake, E.R., Rodnick, J.E., Tobolic, T., et al. (2007). Management of venous thromboembolism: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Annals of Internal Medicine, 146, 204-210.
28. Stanford School of Medicine. (2007). Molecular genetic pathology. Thrombosis risk factors. Retrieved February 12, 2007, from http:// moleculargenetics.stanford.edu/thrombosis.html
29. Van Ha, T. (2006). Complications of inferior vena caval filters. Seminars in Interventional Radiology, 23, 150-155.
30. Wells, P.S., Anderson, D.R., Bormanis, J., Guy, F., Mitchell, M., Gray, L., et al. (2002). Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet, 350, 1795-1798.
31. Wells, P.S., Anderson, D.R., Rodger, M., Forgie, M., Kearon, C., Dreyer, J., et al. (2003). Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. New England Journal of Medicine, 349, 1227-1235.
32. Wen, P.Y., & Marks, P.W. (2002). Medical management of patients with brain tumors. Current Opinion in Oncology, 14, 299-307.